European Research Ranking
Home
Methods
Rankings
Institutions
Countries
Updates
Search
Feedback
Projects
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O
- Germany
Project overview (since 2010-01-01):
Start date
Project
acronym
role
funding
partners
2016-04-01
Remote Assessment of Disease and Relapse in Central Nervous System Disorders - Sofia ref.: 115902
RADAR-CNS
participant
11.000.000
25
2016-01-01
Ears, Eyes and Mind: The ‘SENSE-Cog Project’ to improve mental well-being for elderly Europeans with sensory impairment
SENSE-Cog
participant
6.541.591
20
2016-01-01
Folate-Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis
FOLSMART
participant
4.993.834
11
2016-01-01
Small vessel diseases in a mechanistic perspective: Targets for Intervention Affected pathways and mechanistic exploitation for prevention of stroke and dementia
SVDs-at-target
participant
5.998.300
13
2015-11-01
RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities
RELENT
participant
5.999.431
15
2015-11-01
Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe hemophilia A
HemAcure
participant
5.564.395
8
2015-07-01
Diamond materials for the photocatalytic conversion of CO2 to fine chemicals and fuels using visible light
DIACAT
participant
3.872.980
9
2015-06-01
PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke
PRECIOUS
participant
5.994.000
17
2015-01-01
Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes
TREGeneration
participant
5.899.250
8
2013-11-01
Targets and biomarkers for antiepileptogenesis
EPITARGET
participant
11.999.975
18
2013-11-01
Labeling of Enalapril from Neonates up to Adolescents
LENA
participant
5.999.991
12
2013-10-01
Personalised Prognostic Tools for Early Psychosis Management
PRONIA
participant
6.000.000
11
2013-10-01
Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope
EU-CERT-ICD
participant
5.999.562
19
2013-10-01
Collaborative European NeuroTrauma Effectiveness Research in TBI
CENTER-TBI
participant
29.998.903
38
2013-10-01
Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified.
CFMATTERS
participant
5.999.748
12
2013-09-01
"MicroRNAs in the Pathogenesis, Treatment and Prevention of Epilepsy"
EPIMIRNA
participant
11.586.858
16
2013-09-01
Neurobiology and Treatment of Adolescent Female Conduct Disorder: The Central Role of Emotion Processing
FEMNAT-CD
participant
5.999.241
17
2013-09-01
Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocardial infarction complicated by cardiogenic shock
CULPRIT-SHOCK
participant
5.999.145
17
2013-08-01
New approaches in the development of Hypoallergenic implant material in Orthopaedics: steps to personalised medicine
HYPORTH
participant
5.282.600
8
2013-05-01
Donor T Cells for Immune Control
T-CONTROL
participant
5.682.536
5
2013-01-01
Bioactivated hierarchical hydrogels as zonal implants for articular cartilage regeneration
HYDROZONES
participant
9.749.700
16
2012-12-01
Systems medicine of chronic inflammatory bowel disease
SYSMEDIBD
participant
11.999.998
12
2012-11-01
Emerging mental health systems in low- and middle-income countries
EMERALD
participant
5.798.173
12
2012-10-01
Clinical European study on the outcome of surgical and hormonal therapy and psychological intervention in disorders of sex development (DSD)
DSD-LIFE
participant
2.999.956
16
2012-10-01
Development and clinical trials of a new Software ENgine for the Assessment & Optimization of drug and non-drug Therapy in Older peRsons
SENATOR
participant
5.938.947
12
2012-10-01
European Consortium for High-Throughput Research in Rare Kidney Diseases
EURENOMICS
participant
11.994.567
28
2012-09-01
Resource Preservation by Application of BIOefFECTORs in European Crop Production
BIOFECTOR
participant
5.999.821
23
2012-07-01
Bottom-up reconstitution of a biomimetic bioartificial liver
RE-LIVER
participant
4.234.877
5
2012-02-01
European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke
EuroHYP-1
participant
10.941.665
38
2012-01-01
Disaster Training Curriculum
DITAC
participant
3.498.668
13
2012-01-01
A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease
NILVAD
participant
5.999.978
17
2012-01-01
EUROPEAN FORENSIC GENETICS Network of Excellence
EUROFORGEN-NOE
participant
6.613.680
17
2012-01-01
Developmental Origins of Healthy and Unhealthy Ageing: The Role of Maternal Obesity
DORIAN
participant
2.999.973
10
2011-12-01
Efficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomised, double-blind, placebo-controlled trial
WAKE-UP
participant
11.599.987
13
2011-11-01
Epilepsy Pharmacogenomics: delivering biomarkers for clinical use
EpiPGX
participant
5.997.996
15
2011-10-01
A novel generation of skin substitutes to clinically treat a broad spectrum of severe skin defects
EuroSkinGraft
participant
5.996.018
8
2011-10-01
Cardiovascular Risk from Exposure to Low-dose and Low-dose-rate Ionizing Radiation
PROCARDIO
participant
2.998.387
13
2011-10-01
A Treatment-Oriented Research Project of NCL Disorders as a Major Cause of Dementia in Childhood
DEM-CHILD
participant
2.998.795
13
2011-02-01
European Sequencing and Genotyping Infrastructure
ESGI
participant
9.499.999
11
2011-01-01
European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults
ENS@T-CANCER
participant
5.993.978
16
2010-11-01
Infectious triggers of chronic autoimmunity
INTRICATE
participant
5.965.086
12
2010-10-01
Management of Hypotension In the Preterm Extremely Low Gestational Age Newborn
The HIP Trial
participant
5.355.322
16